Where is the Future of Drug Discovery for Cancer?

    Cell
    |February 11, 2017
    PubMed

    Insights

    Cancer drug discovery is evolving with successful small molecules and biologics. Researchers share visions for identifying and targeting new cancer pathways.

    Area of Science:

    • Oncology
    • Pharmacology
    • Biotechnology

    Background:

    • The landscape of cancer drug discovery is rapidly transforming.
    • Both small molecule drugs and biologic therapies are demonstrating success in clinical trials and patient care.
    • This evolution necessitates novel strategies for identifying and targeting cancer.

    Discussion:

    • Researchers are exploring innovative methods for novel cancer target identification.
    • Approaches to effectively modulate identified cancer targets are under active investigation.
    • The integration of diverse scientific disciplines is crucial for advancing cancer therapeutics.

    Key Insights:

    • The success of current therapies highlights the need for next-generation cancer treatments.
    • Identifying novel molecular targets is paramount for overcoming therapeutic resistance.
    • Developing precise strategies to inhibit or activate these targets is essential for clinical efficacy.

    Outlook:

    • Future cancer drug discovery will likely involve a combination of targeted therapies and immunotherapies.
    • Advanced screening platforms and artificial intelligence will accelerate target identification.
    • Personalized medicine approaches will become increasingly important in tailoring cancer treatments.

    Related Concept Videos

    Drug Discovery: Overview01:26

    Drug Discovery: Overview

    Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
    12.5K
    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
    6.3K
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    9.0K
    Cancer02:18

    Cancer

    Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
    55.2K
    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    3.8K
    Pharmacogenomics: Identification of New Drug Targets01:29

    Pharmacogenomics: Identification of New Drug Targets

    Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
    56